Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May:168:102-107.
doi: 10.1016/j.clineuro.2018.03.001. Epub 2018 Mar 5.

Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China

Affiliations

Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China

Jiaze Tan et al. Clin Neurol Neurosurg. 2018 May.

Abstract

Objectives: Neutral lipid storage disease with myopathy (NLSDM) is a rare metabolic myopathy occurring owing to mutations in the patatin like phospholipase domain containing 2 (PNPLA2) gene. Till date, less than 50 patients with PNPLA2 mutations have been reported. In this study, we describe the clinical, pathological, and genetic findings, and muscle magnetic resonance imaging (MRI) changes in four Chinese patients with NLSDM.

Patients and methods: Peripheral blood smears were stained using Wright's stain. Muscle biopsies, muscle MRI, and sequence analysis of PNPLA2 gene were performed.

Results: All patients exhibited slowly progressive myopathy during adulthood. Cardiomyopathy, sensorineural hearing loss, hepatic adipose infiltration, and hypertriglyceridemia were observed in some patients. Jordan's anomaly was detected in the blood smears of all patients. Muscle biopsies revealed the presence of massive lipid droplets and rimmed vacuoles in two patients. MR images of the lower lumbar, pelvis, and lower extremities showed the involvement of posterior compartment muscles. The anterior compartment muscles were found to be less affected. Gene analysis for PNPLA2 revealed an identical homozygous mutation c.757 + 1G > T in all patients.

Conclusion: Patients with NLSDM display clinical heterogeneities despite sharing the same mutation (c.757 + 1G > T) of the PNPLA2 gene, may suggest a founder effect in the region.

Keywords: Adipose triglyceride lipase (ATGL); Jordan’s anomaly; Muscle pathology; Neutral lipid storage disease with myopathy (NLSDM); Patatin-like phospholipase domain containing 2 (PNPLA2); Rimmed vacuoles.

PubMed Disclaimer

Similar articles

Cited by

Supplementary concepts

LinkOut - more resources